GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (LSE:4BB) » Definitions » Quick Ratio

4basebio (LSE:4BB) Quick Ratio : 3.28 (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is 4basebio Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. 4basebio's quick ratio for the quarter that ended in Jun. 2023 was 3.28.

4basebio has a quick ratio of 3.28. It generally indicates good short-term financial strength.

The historical rank and industry rank for 4basebio's Quick Ratio or its related term are showing as below:

LSE:4BB' s Quick Ratio Range Over the Past 10 Years
Min: 0.88   Med: 5.53   Max: 20.74
Current: 3.28

During the past 4 years, 4basebio's highest Quick Ratio was 20.74. The lowest was 0.88. And the median was 5.53.

LSE:4BB's Quick Ratio is ranked worse than
52.41% of 1555 companies
in the Biotechnology industry
Industry Median: 3.53 vs LSE:4BB: 3.28

4basebio Quick Ratio Historical Data

The historical data trend for 4basebio's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio Quick Ratio Chart

4basebio Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Quick Ratio
0.88 18.92 6.89 3.80

4basebio Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Quick Ratio Get a 7-Day Free Trial 20.74 6.89 4.16 3.80 3.28

Competitive Comparison of 4basebio's Quick Ratio

For the Biotechnology subindustry, 4basebio's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4basebio's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4basebio's Quick Ratio distribution charts can be found below:

* The bar in red indicates where 4basebio's Quick Ratio falls into.



4basebio Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

4basebio's Quick Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Quick Ratio (A: Dec. 2022 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(5.897-0.133)/1.518
=3.80

4basebio's Quick Ratio for the quarter that ended in Jun. 2023 is calculated as

Quick Ratio (Q: Jun. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(5.068-0.199)/1.484
=3.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


4basebio  (LSE:4BB) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


4basebio Quick Ratio Related Terms

Thank you for viewing the detailed overview of 4basebio's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


4basebio (LSE:4BB) Business Description

Traded in Other Exchanges
Address
25 Norman Way, Over, Cambridge, GBR, CB24 5QE
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (LSE:4BB) Headlines

No Headlines